Professor Park Joon-sik of obstetrics and gynecology at Soonchunhyang University Bucheon Hospital announced on the 14th that ...

The mother of a NSW Central Coast woman who died of cervical cancer has told how her daughter spent more than a year trying ...

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer. Researchers discuss the findings.

An Aiims study suggests lymph node removal after chemotherapy may improve survival in advanced ovarian cancer patients, ...

A recent AIIMS, Delhi study reveals that removing specific lymph nodes from the pelvis and abdomen significantly improves ...

Data shows Norway, which is similar in population size to NZ, increased its five-year survival rates for ovarian cancer from 34.1% to 46.1% in the almost two decades from 1995. In contrast, New ...

Highly promising survival data from OVATION 2 Study of treatment of newly diagnosed advanced ovarian cancer to be presented Initiation of Phase 3 trial sites underway for pivotal study of IMNN-001 ...

Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, necessitating new therapeutic strategies. CDK4/6 inhibitors show promise ...

[5] In 2014 Norway’s ovarian cancer survival rate was the highest of six countries in the International Cancer Benchmarking Partnership (ICBP), which includes Australia, Canada, Denmark ...

Australian fashion retailer Witchery has launched its 17th annual White Shirt Campaign today, in support of the Ovarian ...